Abstract We have used brain tissue from clinically welldocumented and neuropathologically confirmed cases of sporadic Parkinson's disease to establish the transcriptomic expression profile of the medial and lateral substantia nigra. In addition, the superior frontal cortex was analyzed in a subset of the same cases. DNA oligonucleotide microarrays were employed, which provide whole human genome coverage. A total of 570 genes were found to be differentially regulated at a high level of significance. A large number of differentially regulated expressed sequence tags were also identified. Levels of mRNA sequences encoded by genes of key interest were validated by means of quantitative realtime polymerase chain reaction (PCR). Comparing three different normalization procedures, results based on the recently published GeneChip Robust Multi Array algorithm were found to be the most accurate predictor of realtime PCR results. Several new candidate genes which map to PARK loci are reported. In addition, the DNAJ family of chaperones is discussed in the context of Parkinson's disease pathogenesis.
Introduction
Parkinson's disease [PD; Online Mendelian Inheritance in Man (OMIM) 168600] is the second most common neurodegenerative disorder after Alzheimer's disease. Due to demographic ageing [World Health Organization (WHO) Health Report 1998], the incidence of this devastating neurological disorder is expected to increase severalfold over the next decades. A number of mutations have been described which cause rare familial forms of the disease [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , but the vast majority (>85%) of all PD cases are considered sporadic. In the latter "idiopathic" form of PD both genetic and environmental factors are expected to contribute to disease development in keeping with the concept of PD being a complex genetic disorder. Current thinking about the pathogenesis of PD is increasingly focused on disease-causing pathways, some of which have been identified in connection with the rare familial forms of PD. These include the ubiquitin-proteasome system, the mitochondrial respiratory chain and, notably, the alphasynuclein pathway and its associated genes. We are establishing a comprehensive molecular pathological database of sporadic PD to provide a basis for studies into these and other functionally related "PD pathways".
We have studied a clinically well-documented and neuropathologically confirmed cohort of idiopathic PD cases. All cases showed alpha-synuclein immunopathology. Two cases showed additional Alzheimer's disease pathology (an expected frequency), one developed dementia, allowing a diagnosis of Parkinson's disease with dementia (PDD) and one could be classified as dementia with Lewy bodies (DLB) based on clinical course and alpha-synuclein pathology.
The international neuropathological consensus definition of sporadic PD includes an assessment of alpha-synuclein status of the whole brain (http://www.ICDNS.org). However, the human substantia nigra (SN) still represents a key anatomical region of interest in PD because this is the brain area which exhibits extensive and most consistent tissue damage in the disease. Here, characteristic degeneration of dopaminergic nerve cells is easy to recognise. In addition, remaining nerve cells typically show Lewy bodies. Once more than half of the existing nerve cell population has died, parkinsonism manifests itself clinically. It is well known that the lateral SN shows the most pronounced degeneration [11] .
We have determined the whole genome expression profile (complete transcriptome) of the adult SN in 15 PD brain donors, in seven controls (brain donors without neurological disease) and in one disease-specific control (a neuropathologically confirmed case of multiple sclerosis) with histologically intact nigra. In addition, we have compared the expression profile of the lateral and medial SN to the frontal cerebral cortex in a subset of the same cases.
Materials and methods

Case material
The human brain tissue for this study was obtained from the UK Parkinson's Disease Society Tissue Bank at Imperial College London and from the Laboratory of Neuropathology of the University of Liège. In addition, one diseasespecific control was obtained from the UK Multiple Sclerosis Society Tissue Bank at Imperial College London. The basic clinical and neuropathological characteristics of the cases used in the study are shown in Table 1 . A detailed description of the clinical and histological findings in each case will be provided elsewhere (Moran et al., in preparation) . In total, 47 individual tissue samples were analyzed, i.e. 15 . RNA yields were determined using a spectrophotometer (GeneQuantPro), and the quality was assessed using agarose gel electrophoresis. RNA samples were stored at −80°C.
Preparation of target cRNA for microarrays
Target cRNA for microarray analysis was prepared following the manufacturer's protocol (http://www.affymetrix.com) and, essentially, as described previously [12] . In brief, total RNA was used for cDNA synthesis employing the SuperScript double-stranded cDNA synthesis kit (Superscript Choice System, Life Technologies, Gaithersburg, MD) with the T7-(dT) 24 Transcripts were defined as statistically significant (twoclass unpaired significance analysis with unequal variance) when they met the criteria of (a) p<0.001 and (b) an absolute difference in expression of 1.0 log unit (log with base 2) (Fig. 1a) . For comparative purposes, significance analysis was carried out with or without error stabilization (variance inflation which increases precision of the analysis for very low expression values) and p value correction for multiple testing [Bonferroni or Benjamini-Hochberg falsediscovery rate (FDR)], respectively. p values corrected according to the Benjamini-Hochberg method are given in the following text (no error stabilization/variance inflation) except where explicitly indicated.
Real-time PCR assay
DNase-treated RNA was reverse-transcribed with random decamers using a RetroScript kit (Ambion; http://www. ambion.com) following the manufacturer's protocol and then stored at −20°C. Two internal controls were selected based on their consistent expression in normal human brain tissue [14] and as also confirmed in our set of cases: beclin 1 [coiled-coil, myosin-like BCL2-interacting protein (BECN1)] and glutaminyl-tRNA synthetase (QARS). Primers for the above control sequences and alpha-synuclein (SNCA), orphan nuclear receptor (NR4A2 or Nurr1), mitochondrial complex I subunit (NDUFA9) and ubiquitin carboxyl-terminal esterase L1 (UCHL1) were designed using MacVector 7.0 software (Accelrys, Cambridge, UK) and synthesised by Sigma Genosys, Haverhill, UK (http://www.sigma-genosys. com). Primer sequences are shown in Table 2 . Where possible, primers were designed to span intron sequences to detect any genomic contamination. Real-time PCR was performed using Sybr Green I Mastermix (Applied Biosystems, Foster City, CA, USA; http://appliedbiosystems.com) using an ABI PRISM 7700 Sequence Detection System. Each reaction was run in triplicate and contained 1 μl of cDNA template along with 300 nM primer in a final reaction volume of 25 μl. Cycling parameters were 95°C for 10 min, 40 cycles at 95°C for 15 s, 60°C (annealing and extension) for 1 min, with a final extension step at 78-84°C for 20 s. Melting curves were determined using Dissociation Curves 1.0 software (Applied Biosystems). In addition, samples were run on a 3% agarose gel to control for amplification product specificity.
Real-time PCR data were processed using SDS 1.7 software (Applied Biosystems). Data were exported from SDS 1.7, and a normalization factor was calculated, derived from the geometric mean of the internal control genes [15] . Fold differences (relative expression) in PD samples compared to controls were determined using Data Analysis software for Real-Time PCR (DART-PCR Version 1.0) [16] .
Results
We have found that on average, 15,600 (35%) of all genes in the SN received present calls. The difference between PD nigra and control appeared to be predominantly quantitative rather than qualitative, with more than 85% of all genes being shared. A direct comparison of the different normalization procedures (Fig. 1b) revealed very significant differences in the number of identified differentially regulated genes at low significance levels. Results obtained with the three different algorithms were more comparable at p<0.001, although not all priority genes detected using the different algorithms were identical. This demonstrates the need to assess the quality of microarray algorithms through external validation (Fig. 1c) . Fig. 1 a Volcano plot of differentially expressed genes in substantia nigra. The x axis shows differential expression (DE; logarithmic scale), the y axis indicates the respective p value of each sequence. The sequences coloured in red show a differential expression greater or smaller than one (logarithm with base 2, i.e. one log unit representing a 100% difference) and p values smaller than 0.001. There are 570 probe sets fulfilling these criteria. b Comparison of the number of "significant genes" as detected by GC-RMA-, PLIER-and MAS5.0-based analysis procedures. At p<0.05 (no variance inflation, no Bonferroni or Benjamini-Hochberg FDR correction) the PLIER algorithm which takes into account Affymetrix proprietary information on probe behaviour stands out by producing a very large number of significantly regulated genes. The number of significantly regulated genes as detected by the different algorithms compares rather well at p<0.001. This very stringent threshold leaves 570 significantly regulated genes according to the GC-RMA procedure (Fig. 2) . Validation of microarray-based results was achieved using quantitative real-time polymerase chain reaction (qRT-PCR) analysis. Samples from the original RNA extraction used for running the gene chips and additional RNA from independant extractions of the same brain tissue blocks were used, and a close match was observed, with excellent preservation of the original trend (Fig. 1c) . The overall best match was observed for the GC-RMA algorithm. This was in keeping with recently published studies [13] . We therefore decided to use the GC-RMA algorithm as the "gold standard" for our analysis. Further validation of the results obtained in this study came from another microarray project [17] . We compared a list of genes (Table 3) for consistency of expression, up-or down-regulation of the genes under study and preservation of expression trends within each group and found a perfect match of trend for every single probe checked (r= 0.864, Spearman). Accordingly, the list of genes shown in Table 3 can be considered as confirmed PD-associated sequences or a first PD expression signature. Supplemental Fig. 2 Comparison of the number of significant genes in the medial and lateral substantia nigra. For the two analysis results on the left (medial and lateral nigra, respectively) only medial and lateral samples (PD vs control) were compared (two-class unpaired t test, unequal variance, variance inflation, Bonferroni p value correction). It is interesting to note that the observation that some highly significant genes appear to be "specific" to the lateral and medial nigra, respectively (235 and 86, respectively), is paralleled by the fact that the patterns of degeneration in the lateral compared with the medial substantia nigra are known to differ " Fig. 3 Percentage of established genes (non-EST transcripts) serving a known molecular function, representing an established cellular component, participating in known biological processes and forming pathways. Genes are grouped according to their annotations as defined by Gene Ontology (GO; [18] ). In the case of very small group sizes, summary headings were created for functionally related groups. Keys for resolving each summary group are given in Supplementary  Table 1 . a Per cent of non-EST transcripts (51.8% of 570) serving a known molecular function. The insert (pie chart) shows that almost half (48.2%) of the "prioritised genes" do not have a known molecular function. b Per cent of differentially expressed non-EST transcripts (45.2% of 570) categorized according to the cellular component to which they belong. The insert (pie chart) shows that the majority of the "prioritised genes" do not have a known cellular function. c Per cent of non-EST transcripts (49.2% of 570) serving a known biological process. Genes were grouped according to the known biological process in which they are involved; the majority of transcripts (50.8%) cannot be assigned to Gene Ontology categories. d Per cent of highly significant non-EST sequences that are members of established pathways. The pie chart shows that only 11% (63/570) of the regulated transcripts can be assigned to known pathways (GenMAPP/ KEGG). Therefore, the vast majority (89%) of the "prioritised genes" are not part of a known gene regulatory network a b c d Figure 1 shows the pathway relationships of these genes (PathwayAssist programme). We identified 570 sequences ("priority genes") which passed the FDR correction and which were up-or downregulated at least twofold in the parkinsonian nigra (Fig. 1a) . The ratio between up-and down-regulated messages was 1:6. The gene exhibiting the strongest loss of activity was tyrosine hydroxylase (probe 208291_s_at, p=5.29384e−06, DE=−3.88). The highest up-regulation observed was at three log units (800%) with p=7.14996e−05. The highest significance for differential regulation was obtained at p=4.151 48e−08 for one EST at DE=−1.7. Using p<0.001 as the significance threshold and 0.1 log units (approximately 7% difference in expression) as the cut-off for differentially expressed mRNA sequences, 3,224 differentially regulated messages were identified.
The Venn diagram in Fig. 2 shows the intersection of highly significant genes detected in the lateral and medial nigra compared with the total number of nigra genes. The medial and lateral nigra showed significant differences in expression for some genes (86 and 235, respectively). The 466 genes at the intersection of all three groups form the focus of our current analysis. Contained within this group of significant genes are a larger number of ESTs, suggesting that new pathways exist that have so far not been studied in relation to PD pathogenesis. However, it is clear that our list of 570 priority genes is a "working" list and will have to be constantly checked and amended if justified.
Regarding differential regulation of PD-associated genes in the cerebral cortex, we found that some were co-regulated with genes that were differentially expressed in the SN, but we also observed a number of apparently unique ATPase Adenosinetriphosphatase a All probes listed were tested using the Benjamini and Hochberg FDR model b UCHL1 is also a member of the list of priority genes c Some genes associated with risk and age-of-onset in PD are localised to chromosome 1p [22] d Located within the linkage interval encompassing PARK10 [21] transcriptomic profiles which will need to be confirmed. Importantly, it appears that the number of genes showing co-regulation was too high (several observations made, work in progress) to be explained by chance alone, suggesting that at least at the level of the brain, PD may be considered a "systemic" disease. This would be in keeping with the widespread pathology revealed by alpha-synuclein immunocytochemistry.
'Gene ontology' (GO) [18] represents a controlled vocabulary to describe gene and gene product attributes in an organism (http://www.geneontology.org). The three organizing principles of GO are molecular function, biological process and cellular component. The 570 regulated sequences were grouped according to their corresponding annotations (Fig. 3) . It is interesting that for each of the above GO categories, approximately half of the priority sequences could not be assigned to known GO categories (48.2, 54.8 and 50.8%, respectively). Of the priority sequences concerned, 51.8% possess known molecular functions (Fig. 3a) . The most highly represented transcripts in this group are involved in metal ion binding or act as receptors and enzymes. It is notable that a large number of sequences also play a role in DNA and nucleic acid binding. This is of special interest considering that fragmentation of nuclear DNA is an established finding in parkinsonian nigra [19, 20] . Transcripts representative of established cellular components (Fig. 3b) and known biological processes (Fig. 3c) accounted for slightly less than half (45.2 and 49.2%, respectively) of all regulated transcripts. In the cellular component group, genes and functions related to the nucleus, plasma membrane and the membrane fraction represent more than half of all priority transcripts. For the known biological processes, the highest percentage of transcripts were protein synthesis and breakdown (7.4%), signalling (7.9%), cell cycle, growth and development (9.5%) and transport (10.7%). Examining the distribution of highly regulated messages across pathways, only a small minority (11%) could be assigned to established metabolic cascades (GenMAPP/KEGG). The most highly represented include amino acid metabolism, translation factors, cellular signalling and cell adhesion (Fig. 3d) .
Interestingly, a number of our priority messages map to PARK loci, which are likely to harbour as yet unidentified PD-causing genes (Table 4 ). In addition to the gene mapping most closely to the Park10 locus [21] , our full list includes all transcripts (priority genes only) derived from chromosome 1p, in view of a recent publication linking this region to risk and age-of-onset in PD [22] . However, overall and based on GO, only approximately 50% of these transcripts located on 1p have known molecular functions or form part of established biological processes or cellular components (data not shown). Three of the probes mapping to the 1p region, which identify two proteins, i.e. cell division cycle 42 (CDC42) and vav 3 oncogene (VAV3), are involved in the integrin-mediated cell adhesion pathway (GenMAPP). Furthermore, looking at the list of priority genes in greater detail, several up-regulated transcripts were found to be members of the DNAJ family of heat-shock proteins. These include DnaJ (Hsp40) homologue subfamily B, member 1 (DNAJB1) and DnaJ (Hsp40) homologue, subfamily B, member 6 (DNAJB6). The DNAJ family provides important molecular chaperones which have been implicated in the assembly and disassembly of protein complexes, pro-tein folding, renaturation of denatured proteins, prevention of protein aggregation and protein export (http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?b=OMIM). Observed values for those genes were p=0.000212164 and DE=1.4 for DNAJB6 (209015_s_at), p=0.007720513 and DE=1.1 for DNAJB1 (200666_s_at) and p=8.08917e−05 and DE=0.9 for DNAJB2 (202500_at), respectively.
Discussion
The goal of this research programme is to answer the question of which differences in gene expression are responsible for the preferential susceptibility of dopaminergic nerve cells of the SN to dysfunction and eventual cell death. We present for the first time a whole genome expression analysis of the SN of 15 cases of neuropathologically confirmed PD and 8 controls. We have observed a number of highly significant expression differences in this study, and it is important to bear in mind that we have analyzed RNA extracted from whole-tissue rather than individual cell types, and that expression differences are Fig. 4 Identification of novel PD-associated genes belonging to the DnaJ family of heat-shock proteins which have been implicated in protein folding and protein complex dissociation (OMIM). The pathway schematic illustrates that binding of HERPUD1 (homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1) with the proteasome [28, 29] has a negative effect on the regulation and expression of DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1) [30] and DnaJ (Hsp40) homolog, subfamily B, member 6 (DNAJB6) [31] . N, nucleus likely to be a reflection of disease affecting nerve cells as well as glia. We have found that less than 50% of the sequences interrogated by the gene chips were detectable in the SN. Therefore, approximately half of all human genes may be excluded from the search for genes that are of relevance in Parkinson's disease. At the same time we find that the difference between the parkinsonian nigra and control tissue is remarkably quantitative rather than predominantly qualitative.
Only a few publications have so far detailed transcriptomic information on the parkinsonian nigra, and in those studies, genome coverage was restricted to either small Affymetrix HG_Focus arrays [23] or the HG_133A array only [17, 24] . We compared the published gene lists of all three studies and checked for overlap (consistency), examining in detail all genes that are shared between at least two of the data sets. While the study by Hauser et al. 2005 [24] provides limited published information, and none of the top candidates of Grunblatt et al. 2004 [23] could be confirmed in our data set (matching results with seven down-regulated transcripts only, i.e. GBE1, ALDH 1A1, TRIM36, SLC18A2P, TMEM4, HIP2, and NR4A2), we observed excellent agreement between the A chip gene list published by Zhang et al. 2005 [17] and our own data (their study only used the HG_133A chip).
A potentially very important finding of this study concerns a series of 25 sequences which are highly differentially regulated in PD and which map to known PARK loci. Accordingly, these sequences may play a role in sporadic PD and represent candidates for as yet unidentified disease-causing genes. Details of these candidate genes are given in Table 4 .
We and others believe that dysfunction in the ubiquitinproteasome system and cellular stress represent mechanisms behind the irreversible loss of dopaminergic neurones in PD (Duke et al., submitted). Dysfunction of the endoplasmic reticulum (ER) has also been proposed. In this study, we report increased levels of HERPUD1 mRNA in parkinsonian SN, which is the product of a gene that encodes an ER resident protein which is up-regulated in response to ER stress. It is well known that the accumulation of misfolded proteins in ER triggers an "unfolded protein response" (UPR), which increases transcription of genes encoding for ER chaperones and enzymes associated with ER protein degradation [25] . In the normal brain HERPUD1 has been localised to neurones, and it is found in activated microglia in senile plaques in the brains of Alzheimer's disease patients [26] . A microarray study of a 6-hydroxydopamine (6-OHDA)-treated dopaminergic cell line also shows that the neurotoxin stimulates pathways associated with cellular stress and the UPR accompanied by the expression of HERPUD1 [27] . The schematic pathway shown in Fig. 4 illustrates the interaction between homocys teine-inducible, ER stress-inducible, ubiquitin-like domain member 1 (HERPUD1; 217168_s_at, p=0.00 2316407, DE= 0.53) and the proteasome [28, 29] , which is known to negatively influence expression of DNAJB1 [30] and downstream DNAJB6 [31] . DNAJB1 is involved in biological processes (GO) associated with chaperone-cofactor-dependant protein folding (i.e. assisting in the covalent and non-covalent assembly of post-translational proteins and single-chain polypeptides or multi-subunit complexes into the correct tertiary structure) and has a known molecular function interacting selectively with unfolded protein.
Future work will focus on the detailed and individualised expression profile of the priority sequences described here as well as additional members of this data set across various PD brain regions, their cellular localisation in different cell types and a study of their biological function in pathways in vitro and in vivo. Furthermore, a detailed analysis of individual genome usage by each PD case in relation to neuropathological and clinical features will be performed. Finally, we are planning to link our transcriptomic data to additional data layers (proteomics, metabonomics and morphonomics) to obtain a more holistic and refined picture of PD in the context of what we have termed multidimensional tissue analysis (http://www.neurogenetics.net/ Multidimensional.html).
